Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study | Journal of Clinical Pathology

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via ACP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via ACP

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Short report

Feasibility of combined screening for upper gastrointestinal adenocarcinoma risk by serology and Cytosponge testing: the SUGAR study

Online download statistics by month:

Online download statistics by month: June 2019 to January 2021

	Abstract	Full	Pdf
Jun 2019	192	203	23
Jul 2019	381	423	62
Aug 2019	369	364	12
Sep 2019	356	347	21
Oct 2019	206	199	27
Nov 2019	147	142	35
Dec 2019	103	102	65
Jan 2020	71	65	35
Feb 2020	83	80	35
Mar 2020	55	49	18
Apr 2020	47	46	25
May 2020	49	46	11
Jun 2020	77	70	30
Jul 2020	74	72	19
Aug 2020	64	63	11
Sep 2020	44	42	11
Oct 2020	40	39	6
Nov 2020	28	24	11
Dec 2020	36	32	10
Jan 2021	40	38	19
Total	2462	2446	486